- Home
- TTOO vs NTRB Comparison
TTOO vs NTRB Comparison
Compare TTOO & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- NTRB
- Stock Information
- Founded
- TTOO 2006
- NTRB 2016
- Country
- TTOO United States
- NTRB United States
- Employees
- TTOO N/A
- NTRB N/A
- Industry
- TTOO Medical/Dental Instruments
- NTRB Industrial Specialties
- Sector
- TTOO Health Care
- NTRB Health Care
- Exchange
- TTOO Nasdaq
- NTRB Nasdaq
- Market Cap
- TTOO 36.4M
- NTRB 77.9M
- IPO Year
- TTOO 2014
- NTRB N/A
- Fundamental
- Price
- TTOO $0.97
- NTRB $6.17
- Analyst Decision
- TTOO Hold
- NTRB
- Analyst Count
- TTOO 1
- NTRB 0
- Target Price
- TTOO $5.00
- NTRB N/A
- AVG Volume (30 Days)
- TTOO 710.5K
- NTRB 28.2K
- Earning Date
- TTOO 11-13-2024
- NTRB 12-11-2024
- Dividend Yield
- TTOO N/A
- NTRB N/A
- EPS Growth
- TTOO N/A
- NTRB N/A
- EPS
- TTOO N/A
- NTRB N/A
- Revenue
- TTOO $7,164,000.00
- NTRB $1,803,816.00
- Revenue This Year
- TTOO $50.31
- NTRB N/A
- Revenue Next Year
- TTOO $117.92
- NTRB N/A
- P/E Ratio
- TTOO N/A
- NTRB N/A
- Revenue Growth
- TTOO N/A
- NTRB N/A
- 52 Week Low
- TTOO $0.90
- NTRB $1.93
- 52 Week High
- TTOO $8.38
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- TTOO 18.34
- NTRB 50.57
- Support Level
- TTOO $0.90
- NTRB $5.24
- Resistance Level
- TTOO $1.86
- NTRB $6.40
- Average True Range (ATR)
- TTOO 0.15
- NTRB 0.71
- MACD
- TTOO -0.00
- NTRB -0.12
- Stochastic Oscillator
- TTOO 5.72
- NTRB 33.23
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.